Using synthetic biology to preserve medicinal plants

“What we are seeing more and more is a push across all industries to be more environmentally friendly in their operations. Whether it’s packaging or supply chain, we’re seeing companies focus on that, but the one thing we keep seeing is that we need to focus on sustainability more early in the process.“,​explained Grant Smith, Vice President of Corporate Strategy and Chief Brand Officer of Landkind.

“We not only have to focus on the downstream implications of how we ship something or how we package something, but we also have to look at the fundamental sustainability of the product itself. And that’s why we’re so passionate by using synthetic biology to produce our compounds, as this creates opportunities to ensure sustainability by eliminating the need to disrupt the natural ecosystems of medicinal plants.”

The company’s first product, rhodiola, is one of the oldest medicinal plants in existence. It is increasingly becoming part of mainstream wellness products due to its range of health benefits, but experts are increasingly noting the adverse effects of global use on native plant populations. And as Smith pointed out, Rhodiola has recently been upgraded to endangered status.

“That’s why we’re so passionate about using our team’s knowledge of these botanical constituents to ensure that we’re following nature’s plan and the precision engineering of these nature-identical compounds that open them. for consumer use without threatening the future of these medicinal plants”,said Smith.

To learn more about synthetic biology and the technology behind it, listen to the NutraCast.

You can also subscribe on iTunes, Spotify, Stitcher and wherever you get your podcasts.

Alvin J. Chase